Hedman A, Angelin B, Arvidsson A, Dahlqvist R
Department of Clinical Pharmacology, Huddinge University Hospital, Karolinska Institute, Sweden.
Eur J Clin Pharmacol. 1992;42(5):481-5. doi: 10.1007/BF00314854.
The possibility of an inhibitory effect of spironolactone on the biliary clearance of digoxin has been investigated in 6 healthy subjects. Plasma clearance and the renal and biliary clearance of digoxin were determined twice at steady state (digoxin 0.5 to 1 mg.d-1 p.o. for 6 days), alone or in combination with spironolactone 200 mg daily, after an intravenous dose of digoxin (0.7 x oral dose) on Day 7. Plasma and urine were collected for 48 h. Biliary clearance of digoxin was determined on Day 8 by a duodenal perfusion technique. During spironolactone treatment plasma digoxin clearance tended to be lower (255 vs 224 ml/min; P = 0.057) and renal clearance significantly lower (166 vs 144 ml/min), while the biliary clearance of digoxin remained unchanged (106 vs 103 ml/min). Thus, spironolactone reduced the renal clearance of digoxin by an average of 13%, without affecting its biliary clearance.
在6名健康受试者中研究了螺内酯对地高辛胆汁清除率的抑制作用。在第7天静脉注射地高辛(0.7×口服剂量)后,在稳态下(地高辛0.5至1mg·d⁻¹口服6天),单独或与每日200mg螺内酯联合使用时,测定地高辛的血浆清除率以及肾脏和胆汁清除率两次。收集血浆和尿液48小时。在第8天通过十二指肠灌注技术测定地高辛的胆汁清除率。在螺内酯治疗期间,地高辛的血浆清除率趋于降低(255对224ml/分钟;P = 0.057),肾脏清除率显著降低(166对144ml/分钟),而地高辛的胆汁清除率保持不变(106对103ml/分钟)。因此,螺内酯使地高辛的肾脏清除率平均降低了13%,而不影响其胆汁清除率。